Venetoclax combined with FLAG-based chemotherapy induces an early and deep response in mixed-phenotype-acute leukemia.
Amandine SégotGrégoire StalderLaurence de LevalFrançoise SollyJacqueline SchoumansValentin BassetSabine BlumOlivier SpertiniPublished in: American journal of hematology (2021)